https://padlet.com/deepakkumarwts/4n35xl89vop3 P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. Visit us : https://www.psmarketresearch.com en-us 2018-03-08 12:21:41 UTC 2023-09-08 20:10:33 UTC hello@padlet.com deepakkumarwts https://padlet.com/deepakkumarwts/4n35xl89vop3/wish/239607354
Medical waste refers to the waste originated within medical amenities such as hospitals, clinics, veterinary hospitals/clinics, dental practices, physician's offices, laboratories, blood banks and research and development centers (R&D) related to healthcare. The medical waste management program is critical for the public health, environment, and sanitation. Unlike municipal waste treatment the medical waste management involves various stages of waste management, such as accumulation, generation, storage, handling, treatment, transport, and disposal.

See Medical Waste Management report here : http://bit.ly/2IdKzzp

Europe and North America are the major market for medical waste treatment attributed to the stringent environmental and patient’s safety regulations in the region. Asia Pacific market for the medical waste treatment is growing at a significant rate. The strengthening healthcare infrastructure and increasing expenditure of Hospitals towards the waste management is driving the medical waste treatment market in Asia Pacific.

Get report sample here : http://bit.ly/2FrcLgG

Some of the major players operating in global medical waste management market include, Clean Harbors, Inc., Hawaii Bio-Waste Systems Inc. (HBW), Healthcare Environmental Services Group, Medclean Technologies Inc., Medasend Biomedical Inc., Miller Group, Republic Services Inc., Suez Environnement, Waste Management Inc., Aipura LIC, Stericycle Inc. and Gamma Waste Systems

]]> 2018-03-08 12:23:45 UTC https://padlet.com/deepakkumarwts/4n35xl89vop3/wish/239607354 deepakkumarwts https://padlet.com/deepakkumarwts/4n35xl89vop3/wish/240702539 Read market summary report here : http://bit.ly/2GiPL4P

Market Synopsis of Medical Tourism Market

The global medical tourism market is growing significantly due to high cost of healthcare expenditure in developed countries. According to Centers for Disease Control and Prevention, approximately 750,000 U.S. people travel out of the country for medical care each year. In addition, rise in aging population, reduced cost of procedure in developing countries, and high standards of medical care at a reasonable price are expected to support the medical tourism market to grow in the coming years. Aging increases the risk of diseases, such as heart disease, gastrointestinal diseases and lifestyle associated diseases. According to the World Health Organization, the population of 60 years and above is expected to rise to 15% in 2050.

Medical tourism refers to travelling to another country for medical treatment. Patients may go for medical care to another country for a range of reason, such as decreased cost, or to receive a procedure or therapy not available in their country. Services ranging from essential treatment to different kind of alternative treatments are provided through medical tourism. Cosmetic surgery, orthopedic surgery, weight loss surgery, heart surgery, oncologic care, reproductive treatment and dental treatment are some of the common procedures that people undergo on medical tourism.

Request sample report here : http://bit.ly/2HmqTrS

Regional Analysis of Medical Tourism Market

Medical tourism is promoted in countries such as Taiwan, Malaysia, Brazil, India, Singapore, Turkey, South Korea, and Mexico. India and Malaysia are expected to grow with the highest rate in the coming years, due to improving healthcare infrastructure, high healthcare standards with low cost, highly skilled professionals, cost effective treatment for several diseases, increasing government initiatives to improve medical services and availability of technologically advanced solutions for various conditions. Thailand is the most preferred destination among the Western European tourists for cosmetic surgery, and Singapore is specialized in complex procedures. Moreover, medical tourism in Malaysia is also emerging due to increasing government initiatives to improve medical services.

Key Players

Some of the hospitals operating in the medical tourism market are Apollo Hospital Enterprise Limited, Asian Heart Institute, Bumrungrad International Hospital, Min-Sheng General Hospital, Min-Sheng General Hospital, KPJ Healthcare Berhad, Bangkok Hospital Medical Center, Fortis Health Ltd., Prince Court Medical Center, Samitivej Sukhumvit, and Raffles Medical Group.

Access Summary of Report here : https://www.psmarketresearch.com/market-analysis/medical-tourism-market]]> 2018-03-12 06:29:20 UTC https://padlet.com/deepakkumarwts/4n35xl89vop3/wish/240702539 deepakkumarwts https://padlet.com/deepakkumarwts/4n35xl89vop3/wish/241211690
Read summary of market report here: http://bit.ly/2ImwyQ9

Market Synopsis of Laboratory Information System Market:

The global laboratory information systems market is growing moderately, driven by increasing demand for advanced healthcare monitoring systems, better efficiency of laboratories, and hospitals and laboratories prioritizing for information systems. The LIS plays an important role in generating information effectively and accurately, which helps in clinical decisions.

The application market of LIS has been categorized as clinical, drug discover and industrial. By application, the Clinical LIS segment accounted for the largest share in the global LIS market and it reported CAGR of 7.6% during 2011 to 2014, the highest among all segments. The growth of clinical LIS market was mainly driven by increasing numbers of tests and higher cost due to the emergence of new technologies.

Regional Analysis of Laboratory Information System Market:

The application market of LIS has been categorized as clinical, drug discover and industrial. By application, the Clinical LIS segment accounted for the largest share in the global LIS market and it reported CAGR of 7.6% during 2011 to 2014, the highest among all segments. The growth of clinical LIS market was mainly driven by increasing numbers of tests and higher cost due to the emergence of new technologies.

Request sample report here : http://bit.ly/2HsvNns

Key players :

The global LIS market is in growing phase in most of the countries and there are few large vendors holding the significant market share. Many new players are also entering the market, and the consolidation of small players with large players is shaping the competitive landscape. The competition in the LIS market is tough and the market players are trying to sustain themselves by differentiating their LIS products from their competitors. STARLIMS Corporation, Sunquest Corporation, McKesson, LabWare and LabVantage are some of the leading market players offering LIS solutions.



]]> 2018-03-13 06:06:22 UTC https://padlet.com/deepakkumarwts/4n35xl89vop3/wish/241211690 deepakkumarwts https://padlet.com/deepakkumarwts/4n35xl89vop3/wish/243503074
Read market report summary here : http://bit.ly/2FM19sL

The rising number of the research and development activities for the pipeline drugs acts as drivers for the cytomegalovirus infection therapeutics pipeline. The prophylaxis treatment of cytomegalovirus is also increasing due to its effective and safe treatment. The U.S. Food and Drug Administration (USFDA) and European Medicines Agency (EMA) are supporting the cytomegalovirus infection therapeutics pipeline by encouraging the drug development process through different types of designations.

In pipeline drugs, Chimerix Inc., is developing brincidofovir, a Phase III product of a nucleotide analog lipid conjugate. Brincidofovir is an oral and intravenous formulation which blocks replication of double-stranded DNA viruses.

Chimerix is developing the compound for dual use as a medical countermeasure in the event of a smallpox release and as a broad-spectrum antiviral for the treatment of diseases in immunocompromised transplant and cancer patients.

Request report sample here : http://bit.ly/2ppIiZx

Key Players

Some of the companies having a pipeline of cytomegalovirus infection therapeutics include Biotest AG, Merck & Co., Inc., Chimerix Inc., Astellas Pharma, Inc., CSL Behring, Cell Medica Ltd., GlaxoSmithKline plc, Pfizer, Inc., F. Hoffmann-La Roche and AstraZeneca plc.


]]> 2018-03-19 14:02:54 UTC https://padlet.com/deepakkumarwts/4n35xl89vop3/wish/243503074